Our findings in this large multicenter study in National Health Service hospitals in England confirm the prognostic ability of the Ki67 score for breast cancer mortality in women with ER-positive, HER2-negative early IBC. This evidence concerns the gene ESR1 and inflammatory breast carcinoma.